Z51.81 ICD 10 Code is a billable and specific code that can be used to indicate a diagnosis of Encounter for therapeutic drug level monitoring for reimbursement purposes. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.
Type 1 excludes for Z51.81 ICD 10 code
- encounter for blood-drug test for administrative or medicolegal reasons (Z02.83)
Possible back-references that may be applicable or related to Z51.81 ICD10 Code:
- Z00-Z99 Factors influencing health status and contact with health services
- Z40-Z53 Encounters for other specific health care
- Z51 Encounter for other aftercare and medical care
- Z51.1 Encounter for antineoplastic chemotherapy and immunotherapy
- Z51.8 Encounter for other specified aftercare
Present On Admission (POA Exempt)
Z51.81 ICD 10 code is considered exempt from POA reporting